Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin Mechanism in Idiopathic Rhinitis
NCT01862523Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Feb 2012
- Primary completion
- Dec 2014
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of capsaicin 8% patch in idiopathic rhinitis (NAR) (3 arms), sponsored by UZ Leuven. Primary endpoint: Negative Mucosa Potentials at 6 months. Started Feb 2012; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
idiopathic rhinitis (NAR)
Beyond the preview
Go deeper on NCT01862523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01862523.